Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Carbapenem-Resistant Enterobacteriaceae. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 1: All are true about ESBL except -
- A. Resistant to carbapenems (Correct Answer)
- B. Classification is based on 3rd generation cephalosporin sensitivity
- C. Cephalosporin sensitivity testing is required to confirm ESBL
- D. Ambler classification is based on molecular structure
Carbapenem-Resistant Enterobacteriaceae Explanation: ***Resistant to carbapenems***
- **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections.
- Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs.
*Classification is based on 3rd generation cephalosporin sensitivity*
- ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam.
- This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification.
*Cephalosporin sensitivity testing is required to confirm ESBL*
- **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid.
- This testing is crucial for accurate detection and guiding appropriate antibiotic therapy.
*Ambler classification is based on molecular structure*
- The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms.
- This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 2: Which of the following is NOT a mechanism of antibiotic resistance?
- A. Efflux pump activity
- B. Inactivation by enzymes such as beta-lactamase
- C. Modification of drug target sites
- D. Increased drug absorption (Correct Answer)
Carbapenem-Resistant Enterobacteriaceae Explanation: ***Increased drug absorption***
- **Increased drug absorption** would lead to a higher intracellular concentration of the antibiotic, making it *more potent* against the bacteria rather than contributing to resistance.
- Antibiotic resistance mechanisms aim to *reduce the effective concentration* of the drug at its target site or *alter the target itself*.
*Efflux pump activity*
- **Efflux pumps** are bacterial membrane proteins that actively pump antibiotics out of the bacterial cell [3].
- This mechanism *reduces the intracellular concentration* of the antibiotic, preventing it from reaching its therapeutic target [3].
*Inactivation by enzymes such as beta-lactamase*
- Bacteria can produce enzymes like **beta-lactamase** that *chemically modify or degrade* the antibiotic molecule, rendering it inactive [2].
- This is a common mechanism of resistance against **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) [2].
*Modification of drug target sites*
- Bacteria can develop mutations that *alter the structure of the antibiotic's target site*, such as a bacterial ribosome or cell wall component [1].
- This change in the target means the antibiotic can no longer bind effectively or interfere with cellular processes, thus *losing its efficacy* [1].
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 3: Carbapenem which has a tendency to cause maximum seizures?
- A. Imipenem (Correct Answer)
- B. Ertapenem
- C. Doripenem
- D. Meropenem
Carbapenem-Resistant Enterobacteriaceae Explanation: ***Imipenem*** - **Imipenem** is associated with the highest risk of **seizures** among the carbapenems, particularly in patients with **renal impairment**, pre-existing **CNS disorders**, or high doses. - Its high affinity for **GABA-A receptors** in the central nervous system is thought to contribute to its proconvulsant effects. *Ertapenem* - While all carbapenems carry some risk of seizures, **ertapenem** has a **lower incidence** compared to imipenem. - It is often favored in patients without CNS infections or severe renal dysfunction due to its once-daily dosing. *Doripenem* - **Doripenem** also has a relatively **low risk of seizures** compared to imipenem. - It is generally well-tolerated, with side effects similar to other carbapenems but at a reduced frequency for CNS events. *Meropenem* - **Meropenem** is known to have a **lower seizure potential** than imipenem, making it a preferred choice for patients with a history of seizures or those with CNS infections. - Its **reduced affinity** for GABA-A receptors contributes to its better CNS tolerability.
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 4: All the following statements are true regarding beta-lactams except:
- A. Methicillin is not orally bioavailable and is given parenterally.
- B. Imipenem should be given with cilastatin
- C. Meropenem does not require cilastatin for protection against renal toxicity.
- D. Aztreonam shows cross-reactivity with cephalexin. (Correct Answer)
Carbapenem-Resistant Enterobacteriaceae Explanation: ***Aztreonam shows cross-reactivity with cephalexin.***
- **Aztreonam** is a monobactam with a distinct chemical structure from other beta-lactams, resulting in a different **allergy profile** and lack of significant **cross-reactivity** with other beta-lactams, including cephalosporins like cephalexin.
- Its unique structure also means it is specifically active against **gram-negative bacteria** and generally resistant to common beta-lactamases that deactivate other beta-lactams.
*Imipenem should be given with cilastatin*
- **Imipenem** is rapidly metabolized in the renal tubules by **dehydropeptidase-1**, leading to reduced antibiotic concentrations and potential for nephrotoxicity.
- **Cilastatin** is a dehydropeptidase inhibitor that prevents the breakdown of imipenem, ensuring adequate drug levels and reducing renal damage.
*Methicillin is not orally bioavailable and is given parenterally.*
- **Methicillin** is an acid-labile penicillin, meaning it is extensively degraded by stomach acid when taken orally, leading to poor absorption.
- Due to its instability in acidic environments, methicillin must be administered **parenterally (intravenously or intramuscularly)** to achieve therapeutic concentrations.
*Meropenem does not require cilastatin for protection against renal toxicity.*
- **Meropenem** is another carbapenem, but it is much more stable to metabolism by **renal dehydropeptidase-1** compared to imipenem.
- This inherent stability eliminates the need for co-administration with **cilastatin** to prevent its degradation and protect against nephrotoxicity.
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 5: Burkholderia cepacia is resistant to which of the following antibiotics?
- A. Trimethoprim-sulfamethoxazole
- B. Cefotetan (Correct Answer)
- C. Ceftazidime
- D. Temocillin
Carbapenem-Resistant Enterobacteriaceae Explanation: ***Cefotetan***
- *Burkholderia cepacia* shows **consistent resistance** to second-generation cephalosporins and cephamycins like **cefotetan**.
- This organism is intrinsically resistant to **aminoglycosides** (gentamicin, tobramycin) and **polymyxins** (colistin), and shows variable resistance to many beta-lactams.
- Among the options provided, cefotetan represents the most consistently ineffective agent.
*Ceftazidime*
- **Ceftazidime** (third-generation cephalosporin) shows **variable susceptibility** with *B. cepacia*.
- While resistance is common, it is **not uniform**, and ceftazidime is sometimes used in **combination therapy** for B. cepacia infections.
- Not considered a classic example of intrinsic resistance.
*Trimethoprim-sulfamethoxazole*
- **TMP-SMX** is the **first-line treatment** for *Burkholderia cepacia* infections.
- It demonstrates good activity and is the preferred antimicrobial agent for this organism.
- Resistance can develop but is not intrinsic.
*Temocillin*
- **Temocillin** (carboxypenicillin) has demonstrated activity against *B. cepacia*.
- Used particularly in Europe for treating infections caused by this organism.
- Not an antibiotic to which *B. cepacia* shows consistent resistance.
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 6: The ELISA test for virulence antigen is used to diagnose which type of Escherichia coli?
- A. ETEC
- B. EIEC
- C. EPEC (Correct Answer)
- D. EHEC
Carbapenem-Resistant Enterobacteriaceae Explanation: ***EPEC (Enteropathogenic E. coli)***
- The **ELISA test for virulence antigen** is specifically used to detect **Bundle-Forming Pilus (BFP)** and **EAF (E. coli adherence factor) plasmid antigens** in EPEC
- EPEC is a major cause of **infantile diarrhea** in developing countries
- The virulence antigen detection by ELISA is a **standard diagnostic method** for identifying typical EPEC strains
- EPEC demonstrates **localized adherence** pattern on HEp-2 cells and possesses the **LEE (locus of enterocyte effacement) pathogenicity island**
*ETEC (Enterotoxigenic E. coli)*
- ETEC causes **traveler's diarrhea** by producing **heat-labile (LT)** and **heat-stable (ST) enterotoxins**
- Diagnosis involves detecting these **specific toxins or their genes** using PCR or toxin-specific immunoassays
- ELISA for virulence antigens is not the primary diagnostic method for ETEC
*EIEC (Enteroinvasive E. coli)*
- EIEC invades intestinal epithelial cells, causing **dysentery-like illness** similar to *Shigella*
- Diagnosis relies on detecting **invasion plasmid antigen H (IpaH)** or demonstrating **invasive properties** in cell culture assays
- Serotyping and molecular methods are preferred over ELISA for virulence antigens
*EHEC (Enterohemorrhagic E. coli)*
- EHEC (particularly **O157:H7**) produces **Shiga toxins (Stx1 and Stx2)** causing hemorrhagic colitis and HUS
- Diagnosis focuses on detecting **Shiga toxins** using specific ELISA or **stx genes** by PCR
- Sorbitol-MacConkey agar is used for initial screening of O157:H7 strains
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 7: The bacterial drug resistance in tuberculosis results from which mechanism?
- A. Transduction
- B. Transformation
- C. Plasmid mediated resistance
- D. Mutation (Correct Answer)
Carbapenem-Resistant Enterobacteriaceae Explanation: **Explanation:**
The development of drug resistance in *Mycobacterium tuberculosis* (MTB) is unique compared to many other bacteria.
**Why Mutation is Correct:**
In *Mycobacterium tuberculosis*, antimicrobial resistance occurs exclusively due to **spontaneous chromosomal mutations**. Unlike many Gram-negative or Gram-positive bacteria, MTB does not possess horizontal gene transfer mechanisms like plasmids or transposons. These random genetic mutations occur at a predictable frequency (e.g., 1 in $10^6$ to $10^8$ cell divisions). When a patient is treated with inadequate monotherapy or irregular dosing, these resistant mutants are "selected" and survive to multiply, leading to **acquired resistance**.
**Why Incorrect Options are Wrong:**
* **Transduction & Transformation (A & B):** These are forms of horizontal gene transfer involving bacteriophages and the uptake of free DNA, respectively. While common in bacteria like *Staphylococcus* or *Streptococcus*, they have no documented role in clinical drug resistance in MTB.
* **Plasmid-mediated resistance (C):** Plasmids are extrachromosomal DNA elements frequently responsible for multi-drug resistance in Enterobacteriaceae (e.g., via R-plasmids). *M. tuberculosis* does not harbor resistance-carrying plasmids.
**High-Yield Clinical Pearls for NEET-PG:**
* **Multi-Drug Resistant TB (MDR-TB):** Defined as resistance to at least **Isoniazid (H)** and **Rifampicin (R)**.
* **Genetic Targets:**
* **Rifampicin resistance:** Mutation in the **rpoB** gene (beta subunit of RNA polymerase).
* **Isoniazid resistance:** Mutation in **katG** (most common) or **inhA** genes.
* **DOTS Strategy:** The primary reason for using "Multi-Drug Therapy" in TB is to prevent the selection of these spontaneous resistant mutants. The probability of a bacilli developing simultaneous mutations to two drugs is mathematically negligible ($10^{-6} \times 10^{-8} = 10^{-14}$).
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 8: How does Staphylococcus aureus become resistant to methicillin?
- A. Heat shock protein
- B. Protein A
- C. Transpeptidase (Correct Answer)
- D. Protein C
Carbapenem-Resistant Enterobacteriaceae Explanation: ### Explanation
**1. Why Transpeptidase is Correct:**
Methicillin resistance in *Staphylococcus aureus* (MRSA) is primarily mediated by the acquisition of the **mecA gene**. This gene encodes a modified **Penicillin-Binding Protein (PBP2a)**. PBPs are essentially **transpeptidases**, enzymes responsible for cross-linking the peptidoglycan layers of the bacterial cell wall.
While standard PBPs are inhibited by beta-lactam antibiotics (like methicillin or oxacillin), the modified transpeptidase (PBP2a) has a **low affinity** for these drugs. This allows the bacteria to continue cell wall synthesis even in the presence of the antibiotic, leading to resistance.
**2. Why Other Options are Incorrect:**
* **Option A (Heat shock protein):** These are molecular chaperones that help in protein folding and stress response; they do not mediate antibiotic resistance in Staphylococci.
* **Option B (Protein A):** This is a key virulence factor of *S. aureus* that binds to the **Fc portion of IgG**, preventing opsonization and phagocytosis. It is not involved in drug resistance.
* **Option C (Protein C):** This is a host (human) anticoagulant protein that inactivates Factors Va and VIIIa. It has no role in bacterial physiology.
**3. High-Yield Clinical Pearls for NEET-PG:**
* **Gold Standard Test:** The detection of the **mecA gene** by PCR is the gold standard for identifying MRSA.
* **Phenotypic Screening:** Cefoxitin disk diffusion is preferred over methicillin/oxacillin disks for screening MRSA in labs because it is a better inducer of the mecA gene.
* **Drug of Choice:** **Vancomycin** is the traditional drug of choice for MRSA. For VRSA (Vancomycin-resistant), Linezolid or Daptomycin are used.
* **Exceptions:** MRSA is resistant to all beta-lactams **except** 5th generation cephalosporins (e.g., **Ceftaroline**).
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 9: Which of the following is NOT a mechanism of resistance to MRSA?
- A. Resistance is chromosomally mediated.
- B. Produced mainly by alteration in PBPs.
- C. MRSA resistance is absolutely beta-lactamase dependent. (Correct Answer)
- D. Intrinsic resistance is known.
Carbapenem-Resistant Enterobacteriaceae Explanation: **Explanation:**
**Why Option C is the correct answer:**
The hallmark of Methicillin-resistant *Staphylococcus aureus* (MRSA) is that its resistance is **independent** of beta-lactamase production. While many Staphylococci produce penicillinase (a beta-lactamase), MRSA resistance specifically arises from the acquisition of the **mecA gene**. This gene encodes an altered Penicillin-Binding Protein (**PBP2a**), which has a very low affinity for almost all beta-lactam antibiotics (penicillins, cephalosporins, and carbapenems). Therefore, even if a drug is "beta-lactamase stable" (like Methicillin or Nafcillin), it cannot bind to PBP2a, rendering the drug ineffective.
**Analysis of incorrect options:**
* **Option A (Chromosomally mediated):** This is a true statement. The *mecA* gene is located on a mobile genetic element called the **Staphylococcal Cassette Chromosome (SCCmec)**, which integrates into the bacterial chromosome.
* **Option B (Alteration in PBPs):** This is the primary mechanism. The production of **PBP2a** instead of the normal PBPs prevents the antibiotic from inhibiting cell wall synthesis.
* **Option D (Intrinsic resistance):** This is true. MRSA resistance is considered "intrinsic" because it is a structural change in the target site (PBP) that applies to the entire class of beta-lactams, regardless of the presence of enzymes.
**High-Yield Clinical Pearls for NEET-PG:**
* **Drug of Choice for MRSA:** Vancomycin (Glycopeptide).
* **Exception:** 5th generation cephalosporins (**Ceftaroline** and Ceftobiprole) are the only beta-lactams active against MRSA because they can bind to PBP2a.
* **Detection:** Cefoxitin disk diffusion test is the preferred method in labs to detect MRSA (it is a better inducer of the *mecA* gene than methicillin).
* **BORSA:** "Borderline Oxacillin-Resistant *S. aureus*" refers to strains that are resistant due to *hyper-production* of beta-lactamase, not the *mecA* gene.
Carbapenem-Resistant Enterobacteriaceae Indian Medical PG Question 10: Hain test is used for:
- A. Detection of INH resistance only
- B. Detection of rifampicin resistance only
- C. Detection of both rifampicin and INH resistance (Correct Answer)
- D. Detection of resistance to all first-line anti-tuberculosis drugs
Carbapenem-Resistant Enterobacteriaceae Explanation: **Explanation:**
The **Hain test**, also known as the **GenoType MTBDRplus** assay, is a commercial Line Probe Assay (LPA) used for the rapid molecular detection of drug resistance in *Mycobacterium tuberculosis*.
**1. Why Option C is Correct:**
The Hain test utilizes PCR and reverse hybridization to identify specific mutations in the MTB genome. It simultaneously targets:
* **rpoB gene:** Mutations here confer resistance to **Rifampicin**.
* **katG and inhA promoter genes:** Mutations here confer resistance to **Isoniazid (INH)**.
Because it detects resistance to both primary bactericidal drugs, it is the gold standard for the rapid diagnosis of Multidrug-Resistant TB (MDR-TB).
**2. Why Other Options are Incorrect:**
* **Options A & B:** These are incomplete. While the test does detect resistance to these drugs individually, its clinical utility lies in its ability to screen for both simultaneously to identify MDR-TB.
* **Option D:** The Hain test (MTBDRplus) only covers Rifampicin and INH. Resistance to other first-line drugs (Pyrazinamide, Ethambutol) or second-line drugs (Fluoroquinolones, Aminoglycosides) requires different assays, such as the **MTBDRsl** (Second Line) test.
**High-Yield Clinical Pearls for NEET-PG:**
* **Turnaround Time:** Provides results within 24–48 hours, much faster than culture-based DST.
* **Prerequisite:** It can be performed on smear-positive sputum samples or culture isolates.
* **Key Genes to Remember:**
* *rpoB* = Rifampicin
* *katG* (high-level) & *inhA* (low-level) = INH.
* **NTEP Protocol:** In India, LPA is a key component of the Programmatic Management of Drug-Resistant TB (PMDT).
More Carbapenem-Resistant Enterobacteriaceae Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
